2024 |
Q32 Bio Inc.
|
Chief Executive Officer and Director |
- |
- |
2024 |
Verve Therapeutics Inc
|
Independent Director |
- |
- |
2023 |
Rein Therapeutics Inc.
|
Independent Director |
47.9 K |
- |
2023 |
Rein Therapeutics Inc.
|
- |
47.9 K |
- |
2022 |
Rein Therapeutics Inc.
|
Independent Director |
80.4 K |
-46.2 % |
2022 |
Rein Therapeutics Inc.
|
Independent Director |
- |
- |
2021 |
Rein Therapeutics Inc.
|
Independent Director |
149.5 K |
115.6 % |
2020 |
Rein Therapeutics Inc.
|
Independent Director |
69.3 K |
-6.7 % |
2020 |
Akebia Therapeutics Inc.
|
- |
12.5 K |
-92.0 % |
2019 |
Akebia Therapeutics Inc.
|
Director |
156.0 K |
16.9 % |
2019 |
Rein Therapeutics Inc.
|
Independent Director |
74.4 K |
-26.2 % |
2018 |
Akebia Therapeutics Inc.
|
Director |
133.4 K |
- |
2018 |
Rein Therapeutics Inc.
|
Independent Director |
100.8 K |
-52.4 % |
2018 |
Eledon Pharmaceuticals Inc
|
- |
17.5 K |
- |
2018 |
Eledon Pharmaceuticals Inc
|
Director |
- |
- |
2017 |
Rein Therapeutics Inc.
|
Independent Director |
211.6 K |
- |
2017 |
Eledon Pharmaceuticals Inc
|
Director |
- |
- |
2016 |
Rein Therapeutics Inc.
|
Independent Director |
- |
- |
2016 |
Eledon Pharmaceuticals Inc
|
Director |
- |
- |
2015 |
Eledon Pharmaceuticals Inc
|
Director, President and Chief Executive Officer |
- |
- |
2014 |
Eledon Pharmaceuticals Inc
|
Director, President and Chief Executive Officer |
- |
- |
2013 |
Eledon Pharmaceuticals Inc
|
Director, President and Chief Executive Officer |
- |
- |